129.00
BATS BZX Real-Time Price
As of 11:03am ET
 -5.06 / -3.77%
Today’s Change
123.73
Today|||52-Week Range
192.15
-16.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$40.7B

Company Description

Shire Plc is a biopharmaceutical company. The company focuses on developing and marketing innovative medicines for patients with rare diseases and other conditions. It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of innovative specialist medicines to meet significant unmet patient needs. The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol. Shire was founded in 1986 and is headquartered in Dublin, Ireland.

Contact Information

Shire Plc
5 Riverwalk
Dublin Dublin 24
P:(531) 429-7700
Investor Relations:
(781) 482-9018

Employees

Shareholders

Mutual fund holders7.11%
Other institutional12.68%
Individual stakeholders--

Top Executives

Dominic BlakemoreCEO & Independent Non-Executive Director
John MillerChief Financial Officer
Howard MayerSenior VP & Head-Research & Development
Matt WalkerHead-Technical Operations
Sheila E. StranksVice President & Deputy Compliance Officer